Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 0

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)

Registration No. 333-290284

<div align='center'>PROSPECTUS

50,000,000 Class A Ordinary Shares

NewGenIvf Group Limited</div>

This prospectus relates to
the resale by the selling securityholders identified in this prospectus (“Selling Securityholders”) of up to 50,000,000 Class
A Ordinary Shares, no par value per share (“Class A Ordinary Shares”), consisting of (i) 20,000,000 Class A Ordinary Shares
issuable by the Company to White Lion Capital, LLC (“White Lion”) in connection with the Common Stock Purchase Agreement
dated as of November 21, 2024, by and between the Company and White Lion (the “White Lion Purchase Agreement”); and (ii)
30,000,000 Class A Ordinary Shares issuable to JAK Opportunities VI LLC upon the conversion of (a) the Remaining Additional Notes (as
defined below), (b) the senior convertible notes exchanged on August 8, 2024 (“Exchange Notes”), (c) the exercise of the
Series A warrants to purchase Class A Ordinary Shares (the “Series A Warrants”), (d) the exercise of Series B warrants to
purchase Class A Ordinary Shares (the “Series B Warrants”), (e) the exercise of Series C warrants to purchase Class A Ordinary
Shares (the “Exchange Warrants” and together with the Series A Warrants and the Series B Warrants, the “Warrants”),
and (f) the New CB Initial Note (as defined below) (the “Resale Shares”). The Resale Shares were issued in private placements
to certain Selling Securityholders.

We are registering the offer
and resale of the Resale Shares to satisfy certain registration rights we have granted. The Resale Shares will be resold from time to
time by the Selling Securityholders listed in the section titled “Selling Securityholders” beginning on page 95.

The Resale Shares represent
more than the number of our outstanding Class A Ordinary Shares, and the sales of the Resale Shares, or the perception that those sales
might occur, could depress the market price of our Class A Ordinary Shares and could impair our ability to raise capital through the
sale of additional equity securities.

Our registration of the securities
covered by this prospectus does not mean that the Selling Securityholders will offer or sell these securities. The Selling Securityholders
may offer all or